AVM
Arch Venture Management Portfolio holdings
AUM
$299M
This Quarter Return
-6.27%
1 Year Return
-19.47%
3 Year Return
-31.35%
5 Year Return
–
10 Year Return
–
AUM
$266M
AUM Growth
+$266M
(+231%)
Cap. Flow
+$175M
Cap. Flow
% of AUM
65.94%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
2
Increased
–
Reduced
1
Closed
1
Top Buys
| 1 |
Beam Therapeutics
BEAM
|
$128M |
| 2 |
RAPP
Rapport Therapeutics
RAPP
|
$86.7M |
Top Sells
| 1 |
OMIC
Singular Genomics Systems, Inc. Common Stock
OMIC
|
$31M |
| 2 |
Denali Therapeutics
DNLI
|
$7.82M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Beam Therapeutics
BEAM
$1.66B
| $128M | 47.94% |
+5,443,039
| New | +$128M |
|
|
RAPP
2
Rapport Therapeutics
RAPP
$643M
| $86.7M | 32.6% |
+3,728,738
| New | +$86.7M |
|
3
Erasca
ERAS
$445M
| $26.1M | 9.81% |
11,055,554
| – | – |
|
|
VERV
4
DELISTED
Verve Therapeutics
VERV
| $9.8M | 3.69% |
2,008,809
| – | – |
|
5
Gossamer Bio
GOSS
$562M
| $7.26M | 2.73% |
8,055,916
| – | – |
|
6
Q32 Bio
QTTB
$20.9M
| $5.75M | 2.16% |
320,482
| – | – |
|
|
UBX
7
DELISTED
Unity Biotechnology
UBX
| $1.36M | 0.51% |
1,004,817
| – | – |
|
|
OMIC
8
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $1.07M | 0.4% |
126,630
-3,672,296
| -97% | -$31M |
|
9
CERo Therapeutics
CERO
$9.06M
| $432K | 0.16% |
1,444,296
| – | – |
|
|
10
Denali Therapeutics
DNLI
$2.23B
| – | – |
-381,249
| Closed | -$7.82M |
|